裸金属支架与药物洗脱支架在经皮冠状动脉介入术治疗中的研究现状  

Research status of bare metal stents and drug-eluting stent in percutaneous coronary intervention therapy

作　　者：岳谦 刘莹莹 伍志庭 邱伟[1] YUE Qian;LIU Yingying;WU Zhiting;QIU Wei(School of Public Health and Health Management,Gannan Medical University,Ganzhou 341000,China)

机构地区：[1]赣南医学院公共卫生与健康管理学院,江西赣州341000

出　　处：《临床医学研究与实践》2023年第6期187-190,共4页Clinical Research and Practice

基　　金：赣南医学院心脑血管疾病防治教育部重点实验室开放课题(No.XN202021)。

摘　　要：经皮冠状动脉介入术(PCI)是一种有利于解除冠状动脉狭窄、改善心肌供血的治疗手段。随着介入材料的发展,裸金属支架(BMS)和药物洗脱支架(DES)在临床中已被广泛使用,患者术后的支架内再狭窄(ISR)、靶血管血运重建(TVR)、支架内血栓(IST)以及主要心血管不良事件(MACE)的发生率已成为研究的热点。本文就BMS和DES应用于PCI治疗的研究现状作一综述,以期为临床选择介入材料提供有益的指导。Percutaneous coronary intervention(PCI)is a treatment method that is beneficial to relieve coronary artery stenosis and improve myocardial blood supply.With the development of interventional materials,bare metal stents(BMS)and drug-eluting stents(DES)have been widely used in clinical practice,and the incidences of postoperative in-stent restenosis(ISR),target vessel revascularization(TVR),in-stent thrombosis(IST)and major adverse cardiovascular events(MACE)has become a research hotspot.This article review the research status of BMS and DES in the treatment of PCI,in order to provide useful guidance for clinical selection of interventional materials.

关 键 词：裸金属支架 药物洗脱支架 经皮冠状动脉介入术 

分 类 号：R541.4[医药卫生—心血管疾病]